Copertina

EXPRESSION OF CONCERN : Overlapping and Distinct Role of CXCR7 ‐ SDF ‐1/ ITAC and CXCR4 ‐ SDF ‐1 Axes in Regulating Metastatic Behavior of Human Rhabdomyosarcomas

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2026
Soggetti:	International Journal of Cancer
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

The CXCL12 – CXCR4 / CXCR7 axis as a therapeutic target in liver cancer: Enhancing immune evasion and the future of combination therapies
di: Meiying Song, et al.
Pubblicazione: (2026)

C‐X‐C chemokine receptor CXCR4 mediates diurnal changes in the aggregation and dispersion of CD8 + T cells within the tumor microenvironment
di: Akito Tsuruta, et al.
Pubblicazione: (2025)

EXPRESSION OF CONCERN : Antitumor Effects of a Novel Sulfur‐Containing Hydroxamate Histone Deacetylase Inhibitor H40
Pubblicazione: (2025)

EXPRESSION OF CONCERN: Therapeutic targeting of chemoresistant and recurrent glioblastoma stem cells with a proapoptotic variant of oncolytic herpes simplex virus
Pubblicazione: (2024)

Neutralization of IL ‐17 and CXCR1 Protects Septic Arthritis by Regulating CXCL8 ‐ CXCR1 Pathway Along With Functional Activities in Neutrophils
di: Sharmistha Ghosh, et al.
Pubblicazione: (2025)

Structural Basis of CXCR4 Sulfotyrosine Recognition by the Chemokine SDF-1// CXCL12
di: Veldkamp, C., Seibert, C., Peterson, F., Haugner, J
Pubblicazione: (2009)

The SDF‐1/CXCR4 axis is involved in adipose‐derived stem cell migration
di: Jiang Li, et al.
Pubblicazione: (2024)

Can Response Outcomes Predict Survival in Paediatric Patients Receiving Treatment for Relapsed and Refractory Rhabdomyosarcoma? Results From the Living‐ REFoRMS Systematic Review
di: Preethi Muthukumar, et al.
Pubblicazione: (2026)

Real‐World Outcomes of Nivolumab and Ipilimumab in Metastatic Melanoma as Third Line and Beyond
di: Yago Garitaonaindia, et al.
Pubblicazione: (2026)

RETRACTION : Development of Resistance to Chemotherapeutic Drugs in Human Osteosarcoma Cell Lines Largely Depends on Up‐Regulation of Clusterin/Apolipoprotein J
Pubblicazione: (2026)

Sodium Hyaluronate‐ PDGF Repairs Cartilage and Subchondral Bone Microenvironment via HIF ‐1α‐ VEGF ‐Notch and SDF ‐1‐ CXCR4 Inhibition in Osteoarthritis
di: Zhengchao Wang, et al.
Pubblicazione: (2025)

Clinical Outcomes of HER2‐Low Versus HER2‐Zero in HR‐Positive Metastatic Breast Cancer Treated With Endocrine Therapy With or Without CDK4/6 Inhibitors: A Multicenter Retrospective Study
di: Thiti Susiriwatananont, et al.
Pubblicazione: (2025)

T‐Cell Immunoglobulin and Mucin Domain 1 (Tim1) as a Prognostic Factor Associated With Therapeutic Resistance in Human Breast Carcinoma
di: Mio Yamaguchi-Tanaka, et al.
Pubblicazione: (2026)

Regulation of pyruvate dehydrogenase complex: Dancing to different drums in cancer
di: Mulchand S. Patel, et al.
Pubblicazione: (2025)

Regulation of endoplasmic reticulum–mitochondria transfer and its importance in GBM
di: Jinyi Zhao, et al.
Pubblicazione: (2025)

Genetic variants linked to type 2 diabetes in CDKN1B and TCF7L2 influence survival outcomes in metastatic colorectal cancer
di: Raffaella Ruggiero, et al.
Pubblicazione: (2025)

Expression of the CXCR4 S338X Variant Improves Anti‐Leukemia Efficacy of Anti‐ CD19 CAR ‐T Cells
di: Yushu Mao, et al.
Pubblicazione: (2025)

Roles of leukemia inhibitory factor receptor in cancer
di: Wei Ma, et al.
Pubblicazione: (2024)

Human sporadic breast carcinoma histotypes driven by the Human Betaretrovirus homologous to Mouse Mammary Tumor Virus
di: Prospero Civita, et al.
Pubblicazione: (2025)

Tumor‐Associated Macrophage‐Derived CXCL1 Promotes Endometrial Cancer Progression Through the CXCR2/NF‐κB Pathway
di: Ruiqi Xia, et al.
Pubblicazione: (2026)

RETRACTION : Hsp27 Regulates EGF /β‐Catenin Mediated Epithelial to Mesenchymal Transition in Prostate Cancer
Pubblicazione: (2025)

High potassium enhances the immunosuppressive function of myeloid‐derived suppressor cells via Kir4.1‐dependent metabolic reprogramming and promotes tumor immune escape
di: Zhiqi Xie, et al.
Pubblicazione: (2025)

The risk of treatment‐related toxicities with PD‐1/PD‐L1 inhibitors in patients with lung cancer
di: Hao Hu, et al.
Pubblicazione: (2024)

Inhibition of the Rho / MRTF pathway improves the response of BRAF ‐resistant melanoma to PD1 / PDL1 blockade
di: Bardees M. Foda, et al.
Pubblicazione: (2024)

Role of artificial intelligence applied to ultrasound in gynecology oncology: A systematic review
di: Francesca Moro, et al.
Pubblicazione: (2024)

Effects of MCL‐1 expression in colorectal cancer
di: Jessamy Adams, et al.
Pubblicazione: (2024)

Prognostic and predictive implications of sterile alpha motif and HD domain‐containing protein 1 (SAMHD1) expression in breast cancer
di: Maria Kouvaraki, et al.
Pubblicazione: (2024)

Role of the perinatal experience on the risk of acute leukemia in childhood or adolescence: Systematic review and meta‐analysis
di: Jessica Blanco‐Lopez, et al.
Pubblicazione: (2025)

CTHRC1 promotes bone metastasis in prostate cancer
di: Yuichiro Sawada, et al.
Pubblicazione: (2025)

Neoadjuvant chemotherapy with docetaxel, oxaliplatin, and S‐1 versus oxaliplatin and S‐1 for locally advanced gastric adenocarcinoma: A multicenter, real‐world cohort study
di: Peng Jin, et al.
Pubblicazione: (2025)

Comparative efficacy and safety of PD‐1 versus PD‐L1 inhibitors in breast cancer treatment: A systematic review and meta analysis
di: Xintong Xie, et al.
Pubblicazione: (2024)

Comments on “CTHRC1 promotes bone metastasis in prostate cancer”
di: Yongzheng Han, et al.
Pubblicazione: (2025)

EXPRESSION OF CONCERN: Mechanisms of Synthetic Serine Protease Inhibitor (FUT‐175)‐Mediated Cell Death
Pubblicazione: (2025)

Intratumoral delivery of a highly active form of XCL1 enhances antitumor CTL responses through recruitment of CXCL9‐expressing conventional type‐1 dendritic cells
di: Momo Kamei, et al.
Pubblicazione: (2024)

Awareness of Human Papillomavirus ( HPV ), Increasing Rates of Oropharyngeal Cancer, and Estimated Economic Burden in Denmark
di: Kathrine Kronberg Jakobsen, et al.
Pubblicazione: (2026)

Health Care Policy Implementation Trial of Primary Human Papillomavirus–Based Cervical Screening in Denmark
di: Jesper Bonde, et al.
Pubblicazione: (2026)

Adjuvant treatment with anti‐ PD ‐1 in acral melanoma: A nationwide study
di: Manja Bloem, et al.
Pubblicazione: (2024)

The interaction of PRDX1 with Cofilin promotes oral squamous cell carcinoma metastasis
di: Yajun Shen, et al.
Pubblicazione: (2024)

Comments on “Trends and Epidemiology of Human Papillomavirus‐Related Oropharyngeal Cancer in Chinese Populations From 2010 to 2024”
di: Hongshuai Liu, et al.
Pubblicazione: (2026)

Characteristics and overall survival in patients with T1 melanoma: A nationwide matched cohort study
di: Ylva Naeser, et al.
Pubblicazione: (2025)